Zenmark Healthcare Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 20 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.00 M
- Revenue Growth 1.73%
- Profit Growth 2.66%
- Ebitda 21.77%
- Net Worth -18.89%
- Total Assets -22.51%
About Zenmark Healthcare
Zenmark Healthcare Private Limited (ZHPL) is a Private Limited Indian Non-Government Company incorporated in India on 11 October 2004 and has a history of 20 years and four months. Its registered office is in Muzaffarnagar, Uttar Pradesh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹2.00 M.
Gaurav Jain and Atul Jain serve as directors at the Company.
Company Details
- Location
Muzaffarnagar, Uttar Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U85110UP2004PTC029156
- Company No.
029156
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Oct 2004
- Date of AGM
20 Aug 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Who are the key members and board of directors at Zenmark Healthcare?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Gaurav Jain  | Director | 11-Oct-2004 | Current |
| Atul Jain | Director | 19-Nov-2016 | Current |
Financial Performance of Zenmark Healthcare.
Zenmark Healthcare Private Limited, for the financial year ended 2016, experienced modest growth in revenue, with a 1.73% increase. The company also saw a slight improvement in profitability, with a 2.66% increase in profit. The company's net worth observed a substantial decline by a decrease of 18.89%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Zenmark Healthcare?
In 2017, Zenmark Healthcare had a promoter holding of 50.00% and a public holding of 50.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Relief Biotech Private LimitedGaurav Jain and Atul Jain are mutual person
Aru Healthcare Private LimitedGaurav Jain is a mutual person
- Doon Infradeveloper Private Limited
Atul Jain is a mutual person
Charges (Loans)
₹2.00 M
₹0
Charges Breakdown by Lending Institutions
- Punjab National Bank : 0.20 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 23 Aug 2011 | Punjab National Bank | ₹2.00 M | Open |
How Many Employees Work at Zenmark Healthcare?
Unlock and access historical data on people associated with Zenmark Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Zenmark Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Zenmark Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
